Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -6.67% is 76% above its 5-year average of -28.14%, near the high end of its 5-year range (-43.91%–-6.67%).
As of the fiscal period ended Tuesday, June 30, 2026. 58.16% above its 12-month average of -15.94%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -6.67%.
RETURN ON INVESTED CAPITAL (ROIC)
-6.67%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-15.94%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-28.97%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-28.14%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+58.16%
CURRENT VS 3Y AVG
+76.98%
CURRENT VS 5Y AVG
+76.30%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-26.34%
median of 420 covered companies
CURRENT VS SECTOR MEDIAN
+74.68%
vs the sector median at left
Adaptive Biotechnologies Corporation
Market Cap
$4.78B
Return on Invested Capital (ROIC)
-6.67%
TTM Avg
-15.94%
3Y Avg
-28.97%
5Y Avg
-28.14%
Market Cap
$4.81B
Return on Invested Capital (ROIC)
-23.81%
TTM Avg
-42.00%
3Y Avg
-57.33%
5Y Avg
-55.42%
Market Cap
$4.92B
Return on Invested Capital (ROIC)
-18.48%
TTM Avg
-32.11%
3Y Avg
-33.07%
5Y Avg
-32.00%
Market Cap
$5.02B
Return on Invested Capital (ROIC)
6.39%
TTM Avg
-7.12%
3Y Avg
-17.71%
5Y Avg
-17.71%
Market Cap
$4.50B
Return on Invested Capital (ROIC)
-23.69%
TTM Avg
-46.07%
3Y Avg
-46.68%
5Y Avg
-46.68%
Market Cap
$5.11B
Return on Invested Capital (ROIC)
-38.03%
TTM Avg
-36.93%
3Y Avg
-41.32%
5Y Avg
-48.18%
Market Cap
$5.20B
Return on Invested Capital (ROIC)
-90.04%
TTM Avg
-83.71%
3Y Avg
-67.61%
5Y Avg
-57.95%
Market Cap
$5.20B
Return on Invested Capital (ROIC)
5.80%
TTM Avg
5.65%
3Y Avg
5.40%
5Y Avg
4.23%
Market Cap
$4.34B
Return on Invested Capital (ROIC)
-48.57%
TTM Avg
-35.38%
3Y Avg
-31.64%
5Y Avg
-25.98%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Adaptive Biotechnologies Corporation (ADPT) | $4.78B | -6.67% | -15.94% | -28.97% | -28.14% |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.81B | -23.81% | -42.00% | -57.33% | -55.42% |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.92B | -18.48% | -32.11% | -33.07% | -32.00% |
| BillionToOne, Inc. (BLLN)vs › | $5.02B | 6.39% | -7.12% | -17.71% | -17.71% |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.50B | -23.69% | -46.07% | -46.68% | -46.68% |
| Erasca, Inc. (ERAS)vs › | $5.11B | -38.03% | -36.93% | -41.32% | -48.18% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.20B | -90.04% | -83.71% | -67.61% | -57.95% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.20B | 5.80% | 5.65% | 5.40% | 4.23% |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.34B | -48.57% | -35.38% | -31.64% | -25.98% |
| Cogent Biosciences, Inc. (COGT)vs › | $5.27B | -50.09% | -69.73% | -67.26% | -56.46% |
ROIC
-6.7%
ROE
-44.7%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -6.67% |
| 2026-03-31 | -10.78% |
| 2025-12-31 | -13.09% |
| 2025-09-30 | -19.20% |
| 2025-06-30 | -29.94% |
| 2025-03-31 | -33.90% |
| 2024-12-31 | -36.83% |
| 2024-09-30 | -42.43% |
| 2024-06-30 | -43.91% |
| 2024-03-31 | -40.68% |
| 2023-12-31 | -39.61% |
| 2023-09-30 | -31.26% |
| 2023-06-30 | -28.34% |
| 2023-03-31 | -27.70% |
| 2022-12-31 | -26.80% |
| 2022-09-30 | -28.53% |
| 2022-06-30 | -33.59% |
| 2022-03-31 | -31.05% |
| 2021-12-31 | -25.81% |
| 2021-09-30 | -22.02% |
| 2021-06-30 | -18.80% |
| 2021-03-31 | -16.52% |
| 2020-12-31 | -15.11% |
| 2020-09-30 | -13.35% |
| 2020-06-30 | -14.94% |
| 2020-03-31 | -11.67% |
| 2019-12-31 | -9.40% |
| 2019-09-30 | -8.10% |
| 2019-06-30 | -11.29% |
| 2019-03-31 | -10.28% |
| 2018-12-31 | -16.06% |
